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PATIENT-BASED INTERVENTIONS IN THE TREATMENT OF ANV

The Implication of Patient-Based Behavioral Interventions Leading to a More Effective
Treatment of Anticipatory Nausea and Vomiting in Cancer Patients
Katelyn Delaney
Western Michigan University

PATIENT-BASED INTERVENTIONS IN THE TREATMENT OF ANV
Abstract
In the last thirty years, greater attention has been drawn to the aggressive methods of cancer treatment
and the aversive conditioned symptoms they come to elicit. Anticipatory nausea and vomiting is one
such aversive conditioned side effect and is significantly prevalent in cancer patients who undergo
treatments like chemotherapy. In response to the ineffectiveness of pharmacological interventions to
control these symptoms, behavioral intervention methods have grown as a topic of research. The
implications of these behavioral interventions (including cognitive/attentional distraction, meditation
and systematic desensitization) have proven effective in the treatment of the anticipatory nausea and
vomiting and reducing patient anxiety. However, the choice of these interventions fails to take into
account a patient’s individual characteristics, backgrounds and risk factors. The strength of a patient’s
anxiety and preconceived expectations of treatment can also have an effect on the development of ANV
and should be considered. Analyzing how anticipatory nausea and vomiting develops and the
associated risk factors for its development can establish a better understanding of which intervention
will be most effective. A more tailored treatment plan might increase effectiveness and overall quality
of treatment for cancer patients undergoing chemotherapy. In the age of evidence-based practice, when
the gold standard randomized control trial speaks only to the most general case, it is appropriate to
draw upon suitable case studies to assist adapting empirically supported interventions to the individual
case. Such is the aim of this review with respect to selecting the choice of behavioral interventions for
ANV.
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The Implications of Patient-Based Behavioral Interventions Leading to More Effective
Treatment of Anticipatory Nausea and Vomiting in Cancer Patients
Most people are somewhat familiar with cancer; what a diagnosis involves; and the most
popular methods of treatment. Still, there are many facets of this diagnosis that remain unknown except
for those who study, observe or experience them first hand. While it is common knowledge that
chemotherapy causes many undesirable side effects such as nausea and vomiting following treatment,
what is less known is that for some, these symptoms can start before the chemotherapy is even
administered in a condition known as anticipatory nausea and vomiting (ANV) (Morrow & Dobkin,
1988; Carey & Burish, 1988).
The prevalence of ANV can be hard to determine. The absence of a precise definition of ANV
as well as the many different ways ANV is measured in different studies has led to a variety of different
estimations (Burish & Carey, 1986). Also, patients with different types of cancer, and therefore
different chemotherapy treatments, are often lumped together in the same data or there is only data for
one specific type of cancer and chemotherapy. A study by Burish and Carey (1986) took 3 prospective,
longitudinal studies on ANV (Andrykowski et al., 1985; Jacobsen et al., 1985; Love et al., 1985) and
combined their data, which showed a prevalence rate in adults that may be as high as forty-five percent.
Another study estimated that ANV occurs in approximately one out of every three patients receiving
chemotherapy, while anticipatory vomiting appears to occur in about one in every ten (Morrow et al.,
1998). Prevalence rates matching Morrow's estimations seem to be used most frequently in various
studies on ANV.
It is the primary thesis of the present paper that anticipatory nausea and vomiting (ANV) can be
best described through classical conditioning. A neutral stimulus (smell of the chemotherapy
environment) is paired with an unconditioned stimulus (chemotherapy drugs) that elicits an
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unconditioned response (post chemotherapy nausea and vomiting). After a few pairings, the smell of
the chemotherapy room becomes a conditioned stimulus and is able to elicit a conditioned response. A
variety of previously neutral stimuli that are seen, heard, smelled or even tasted before or during the
first few chemotherapy infusions are paired with the nausea and vomiting induced by the chemotherapy
and are then able to elicit these aversive effects, even when the chemotherapy drugs are not present. An
environmental stimulus paired with the drug can be the smell of the car used to drive to treatment, the
sight of the chair in which the chemotherapy is administered, or even food and drink consumed at times
surrounding the treatment.
In one experimental study, breast cancer chemotherapy outpatients were exposed to a distinctive
stimulus (a novel beverage) before each infusion. After repeated infusions of chemotherapy, patients’
responses to the experimental stimulus were assessed. They were shown to have had increased nausea
following the presentation of the beverage even when no chemotherapy infusion took place (Bovberg et
al., 1992). Bovberg et al. (1992) stated that, "This conditioning model of anticipatory nausea bears
witness to the relevance of classical conditioning in clinical medicine". It is true that classical
conditioning remains one of the best explanations for the development of this condition. Based on
classical conditioning experiments conducted on animals, the severity of anticipatory nausea should
increase as the time for the scheduled chemotherapy infusions draws near. Results in a study by
Montgomery and Bovberg (1997) revealed such a pattern. Anticipatory nausea became stronger in the
time period closest to the chemotherapy infusion. Nausea in the clinic before treatment infusions was
the greatest, while nausea at home the morning of chemotherapy showed moderate increases, and
nausea experienced the night before chemotherapy did not increase significantly. Findings from this
study indicate that the severity of anticipatory nausea increases with the number of infusion cycles
received and that the nausea is relative to the time that the patient's scheduled infusion is to take place.
These results are consistent with conditioned learning. In addition, ANV prior to any chemotherapy is
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rare, and post-treatment nausea or emesis must occur before development of ANV can take place
(Morrow & Rosenthal, 1996). Once these previously neutral stimuli have been paired and are able to
produce the conditioned response it can be hard or even impossible to avoid them, especially if there
are a variety of different conditioned stimuli acting concurrently. The patient's routine as well as stable
features of their environment likely remain unchanged on treatment days, making these pairings even
more probable and intense.
One question surrounding the development of ANV and its prevalence is that if classical
conditioning is at work, why doesn’t everyone experience ANV? Shouldn't ANV occur in all patients
who undergo chemotherapy? While there is no definite answer to these inquiries, certain risk factors
can in fact increase the likelihood of ANV. Identifying patients who are more likely to develop the
conditioned symptoms can allow for early and targeted use of interventions, and provide a greater
understanding of how this condition develops. Preventing nausea and vomiting from the very first
exposure to chemotherapy is ideal, and as a result, knowing who is more susceptible to its development
can have a key influence in its treatment. One characteristic that increases the risk of developing
conditioned responses is being younger rather than older (Cohen et al., 1986). Younger patients who
experience severe or frequent nausea or vomiting after their treatment are at particularly high risk
(Roscoe et al., 2011). Other risk factors include being female, the patient's pre-treatment expectation
about nausea (Hickok et al., 2001; Montgomery et al., 1998), a patient’s level of anxiety (Andrykowski,
1990), having an inhibitive rather than facilitative coping style, having parents with high anxiety levels
(in pediatric or young adult patients), and susceptibility to motion sickness or nausea during pregnancy
(Carry & Burish, 1988). Knowing which factors may have caused an individual to be more susceptible
to ANV can help narrow down the most effective treatment plan to combat the conditioned responses.
For instance, if a patient is known to suffer from high levels of anxiety in day-to-day life, facilitating
relaxation before treatment can be considered since it is known that anxiety during the infusions plays a
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key role in the development of ANV. Screening following the first chemotherapy infusion could
therefore identify those patients at increased risk.
Pharmacological and Nonpharmacological Interventions
Commonly, only pharmacological interventions are used to treat the nausea and vomiting
caused by chemotherapy. Aversive, post-chemotherapy side effects can be treated with nausea
medication or anti-anxiety pills and are also used to control the anticipatory nausea, vomiting, anxiety
and distress that take place before a chemotherapy infusion. The use of these medicines provides some
relief for chemotherapy-induced nausea and vomiting, but does not seem to control ANV (FigueroaMoseley et al., 2007). It was anticipated that pharmacological interventions would decrease the
prevalence of ANV, but studies have reported mixed results. Despite the advances of pharmacological
interventions, ANV is still a clinical problem for those undergoing chemotherapy (Bovbjerg et al.,
1992). The conclusion that these interventions are not proven to be effective in treating ANV makes
behavioral interventions an even more important area of study and is one of the leading reasons as to
why behavioral intervention procedures are now among the most widely offered services at some
cancer centers.
Nonpharmacological interventions based on behavioral research and theory have grown in
popularity and have proven effective, however they tend to focus on the application on the population
at large and not on what works best for different individuals. An analysis of how and why ANV
responses are elicited in an individual along with that patient's history, environment and individual
development of ANV can lead to a better understanding of what interventions might be used to
optimize treatment given different patient backgrounds and experiences. This would allow for a more
effective, individual-based treatment plan instead of using a "one-treatment-fits-all" intervention.
Again, risk factors like past experiences with nausea, existing anxiety disorders, or lack of effective
coping strategies can all affect the development and intensity of ANV. A greater understanding of these
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factors and how interventions affect them might significantly diminish the probability of ANV
occurrence. Incorporating these factors into an analysis of which intervention would prove to be more
effective individuals, based on background and pre-existing conditions has the potential to produce
better treatment plans and more effective outcomes.
The Role of Anxiety and Expectation
In a research study by Andrykowski et al. (1985), it was found that except for post treatment
nausea, state anxiety level was shown to be the best predictor of any single variable in determining
whether a patient developed anticipatory nausea. Although anxiety is not necessary for development of
ANV (Andrykowski & Redd, 1987), it is clear that it plays an important role in the development of
conditioned responses. Several studies found that patients who develop ANV are more likely to be
higher in state or trait anxiety than patients who do not develop ANV (Ingle, Burish, & Wallston, 1984;
Van Komen & Redd, 1985). Nerenz et al. assessed chemotherapy patients' levels of anxiety and noted
whether the patients developed anticipatory nausea before each of their first six infusions. Among
mildly anxious patients, the incidence of anticipatory nausea averaged 9.8%; among the highly anxious,
the incidence averaged 18.1%. Andrykowski et al. (1985) concluded that "anxiety contributes to the
development of anticipatory nausea". Decreasing anxiety through behavioral interventions is promising
in reducing the risk of anticipatory nausea and vomiting.
Preconceptions and attitudes that exist post-treatment can have an effect on the development of
ANV. Cognitive expectations have been shown in experimental settings to directly contribute to the
development of conditioned responses in humans. A study by Montgomery et al. (1998) asked breast
cancer patients to rate their expectations of chemotherapy-induced nausea on a scale of one to three;
one being no expectation of nausea, two not being sure what to expect, and three being a strong
expectation of nausea. The patient's pre-treatment expectations of nausea were predictive of their
development of anticipatory nausea. "Pretreatment expectations made a unique contribution to
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conditioned nausea, after accounting for the strongest conditioning predictors" (Montgomery et al.,
1998). The authors also assessed a patient’s personal history of nausea and vomiting. Past life
experiences like motion sickness, pregnancy or anxiety that cause nausea have been linked to a greater
prevalence in anticipatory nausea and vomiting (Carry & Burish, 1988). If someone has had
significantly negative or a great number of experiences with nausea and vomiting in these types of
situations, expectations can carry over and affect the development of ANV. However the relationship
between expectation and ANV development is not clear. For one, it could be that since the patient has
had notable experiences with nausea in the past, it improves a patient's ability to rightfully predict their
response to chemotherapy. That is, if a patient is familiar with their tendency to become nauseated, say
when pregnant, feeling anxious, or consuming alcohol, they may be better apt to more accurately
predict anticipatory nausea during chemotherapy. Therefore their expectations are founded in being
familiar with and able to predict their somatic symptoms.
Behavioral Interventions
Interventions based on behavioral theory are some of the most promising approaches to the
effective management of the aversive effects of cancer treatment. A meta-analysis of over fifty studies
showed results that indicated behavioral interventions can effectively control ANV in both adult and
pediatric cancer patients and that interventions that integrate behavioral methods can alleviate anxiety
and distress associated with invasive treatments like chemotherapy (Redd et al., 2001). The focus of
many of these interventions is to alter coping skills and environmental and cognitive factors that have
an effect on a person's behavior. Since you cannot change the cancer treatment an individual receives,
focus is put instead on teaching patients behavioral coping skills necessary to control the anxiety,
nausea, and vomiting that the chemotherapy may produce. The patient can then use these coping skills
during the aversive procedures. These interventions can be used in a variety of situations, such as
helping a parent cope with their child's illness or helping a patient deal with pain. In the case of ANV,
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the anxiety and nausea are not eliminated, but behavioral coping skills can help control and alleviate
them.
Several specific interventions that have been used to reduce the aversive side effects of cancer
treatment include cognitive/attentional distraction, hypnosis/distraction imagery, cognitive
management, systematic desensitization, relaxation training and cognitive restructuring. For the sake of
this paper's length, only the most commonly studied or proven effective interventions will be reviewed.
Many similarities exist across these different interventions, along with many procedural variations
when they are implicated to treat patients. There are usually no set guidelines for what constitutes as a
specific intervention, and definitions for procedures like hypnosis and meditation can stir debate. More
needs to be done in narrowing down what each of these interventions should entail and which method
is most empirically sound. In other words, therapy manuals specific to interventions with ANV would
be desirable. Even so, these interventions can be easily summarized into the following six categories.
Each one will be discussed in terms related to treating patients with anticipatory side effects and a brief
review of a corresponding research study will be included.
Cognitive/Attentional Distraction
Cognitive or attentional distraction attempts to control a patient's nausea and distress by
engaging them in a concurrent highly interesting task. The patient's awareness of the aversive stimuli is
blocked and attentional capacity that would otherwise be devoted to pain, nausea, and distress is
instead focused on the activity. Video games are a medium that has been proven effective along with
guided imagery and storytelling. There are many options that can be chosen based on the patient's
interests and skills, making this an individualized treatment where certain distractions (music,
crosswords) may work better than others (reading, drawing). Whatever the distraction, it is only
necessary that the patient's attention is completely involved in the task; otherwise the symptoms can
return as soon as their focus is lost. If full attention cannot be achieved the symptoms cannot be
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controlled since the positive effects of distraction usually only last as long as the patient is actively
engaged. For this reason, using distraction for short procedures like blood draws or injections may be
more effective than trying to maintain distraction during entire chemotherapy infusions. Once a
distraction method is chosen, it can be presented when the patient is most likely to begin feeling
anxious or nauseas.
In the investigative article published by Redd et al. (1987), two studies were conducted to
explore the use of cognitive/attentional distraction using video games to control anticipatory nausea in
pediatric cancer patients receiving chemotherapy. Researchers chose an Atari computer and the
children were allowed to pick popular, commercially available video games to play. In the first study,
nausea was measured in children who played video games during chemotherapy against a control group
of children who did not play video games. In the second, a repeated-measures reversal design
incorporated baseline and intervention measurements in a single chemotherapy session. In other words,
during a single treatment session the children were given video games to play for ten minutes, and then
the video game equipment was disconnected and the patient was reassessed. In both studies, the
children who played video-games reported significantly less nausea. Since the second study collected
data as they introduced and withdrew the video games, causing notable changes in nausea, it can be
concluded that the video games solely influenced the outcome. They also found that the video game
children reported less anxiety while playing.
Hypnosis/Distracting Imagery
When using hypnosis, the patient learns to focus on thoughts or images unrelated to the source
of distress. This intervention usually incorporates the description of quiet, pleasant scenes suggested by
the therapist, but interventions employing hypnosis vary considerably in the treatment strategies (Redd
et al., 2001). Many would categorize the methods hypnosis use as cognitive distraction or relaxation
training. However, a meta-analysis revealed that simply using the term 'hypnosis' when describing the
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intervention can increase its beneficial impact (Kirsch et al., 1995). Still for some, using the word
hypnosis can have a negative connotation that may hinder participation (Hendler & Redd, 1986).
Unlike popular cognitive distraction techniques, hypnosis distracts the patient with guided imagery or
suggested thoughts, not exclusively through absorbing activities.
Marchioro et al. (2000) evaluated the impact of hypnosis on the control of anticipatory nausea
and vomiting using sixteen adult cancer patients. A one hour hypnosis program was initiated after a two
hour progressive muscle relaxation training session. Hypnosis included induction of eye weariness and
eyelid heaviness and suggestions aiming to create a light stage of hypnosis. The therapist also
verbalized pleasant emotional experiences belonging to the patient's personal background. Their results
revealed that ANV symptoms completely disappeared in all patients. Also, responses were greatly
reduced in most patients regarding post chemotherapy nausea and vomiting.
Relaxation Training
There are a number of different relaxation procedures; some of the most popular include passive
relaxation and active relaxation. They mainly differ in the way relaxation is induced. Passive relaxation
uses hypnotic-like suggestions of relaxation, while in active relaxation the patient is first taught how to
tense and release certain muscle groups to induce a relaxed state, which after training can be called
forth as needed in practical situations without the tense-release exercise used during training. The
patient learns to focus on these soothing images and thoughts or on the tensing and relaxing of their
muscles. The patient is then able to control their level of relaxation by harnessing this skill during
aversive procedures. These techniques reduce physiological arousal and attempt to distract or
stop the effect of the stimuli that elicit the ANV and other negative sensations. There are currently no
guidelines for which intervention to use, how they could be combined, or which is most effective, so
much is left up to the therapist. It is known that these interventions work, so a clearer analysis of what
to use and when is needed. Relaxation training involves active patient participation and can help a
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patient feel as though they play a major role in reducing the severity of their side effects. This
realization is important, because the sense of mastery; that is, that a patient can exercise some control
over their symptoms, can help with feelings of depression and helplessness that often manifest in
cancer patients (Burish & Lyles, 1980). Relaxation training and guided relaxation imagery are often
paired together and even considered a single intervention type. Many published articles (Lyles et al.,
1982; Yoo et al., 2005) combine or explore the effectiveness of relaxation training combined with
guided imagery and its positive effects when treating anticipatory symptoms.
A study by Burish & Lyles (1980) also explores the use of both active and passive relaxation to
control anticipatory side effects. Cancer patients that exhibited anticipatory nausea, vomiting and
anxiety were chosen and randomly assigned to either the relaxation training or the no relaxation
training condition. A pre-training (baseline) session included both the patient and nurse reporting on the
patient's nausea. Following the pre-training session, a training session was implemented. Progressive
muscle relaxation training and guided relaxation imagery were given to patients approximately forty
five minutes before the chemotherapy was about to begin. The therapist started the session by
explaining that this interventions goal was to induce a calm and relaxed state, thereby making the
chemotherapy experience less unpleasant and reducing anticipatory symptoms. It was explained that
the ability to relax was a learned skill and would require active participation and practice on behalf of
the patient. Then the therapist demonstrated and discussed the progressive muscle relaxation training
procedure. After the muscle tensing and relaxing procedures were completed, the guided relaxation
imagery procedure began. Shortly after the guided imagery had begun, the nurse would enter and begin
chemotherapy. The therapist would continue with the guided imagery instruction for the entire duration
of the chemotherapy infusion and for five minutes after it had ended. The patient was then told to
practice these techniques at home. During the next two chemotherapy treatments, the patients would no
longer be directed by the therapist and it was up to them to induce a relaxed state. The control group
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received no training and the participants were brought to the same quiet room where they waited for
forty five minutes before their infusion. They were simply told to relax quietly until their treatment was
to begin. At the end of the chemotherapy treatments, patients in the relaxation training condition
reported feeling significantly less anxious, nauseated and distressed. The results suggest that the
relaxation procedures were highly effective in reducing emotional distress typically experienced by
cancer patients before, while being infused with, and immediately after the chemotherapy.
Meditation/Mindfulness
Meditation and mindfulness procedures consist of a broad collection of practices. Activities
considered meditation could include focused breathing or a concentrated effort toward “being” in the
present moment. For mindfulness and meditation, the goal is to self-regulate attention on immediate
experience that allows the patient to recognize events arising in present moment awareness. An
openness to and acceptance of these moment-to-moment experiences is the goal. An important practice
of mindfulness is that the patient is taught to "sit with" their thoughts, feelings and anxiety by learning
to become aware of and accept these stimuli, without trying to control them. This intervention has been
shown to have a positive effect on many facets of physical and mental health in cancer patients (Brown
& Ryan, 2003; Carlson et al., 2003; Speca et al., 2000). Research articles investigating the effects of
meditation and mindfulness on the quality of life of cancer outpatients outside of treatment are
common, but articles that discuss the implications for patients with anticipatory nausea and vomiting
are less so. More research using this procedure in the treatment of anticipatory symptoms needs to be
done.
The impact of mindfulness-based stress reduction on the sleep, mood, stress and fatigue
symptoms in cancer out patients was explored in an investigative article by Carlson & Garland (2005).
Cancer patients underwent an eight week mindfulness-based stress reduction program in the hopes that
it would improve their sleep. Not only was there a significant improvement in sleep, but there was also
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a significant improvement in stress, mood and fatigue. The associations among these changes and
implications for improving quality of life of cancer patients were discussed. Although this study did
not focus on anticipatory nausea and vomiting, it still showed that mindfulness can have a strong effect
on patient's overall wellbeing. Since, as cited earlier in this review, much research has studied the link
between anxiety and the development of ANV, mindfulness can be considered an important
intervention since it has been shown to reduce stress, which could help patients who are susceptible to
conditioned symptoms.
Systematic Desensitization
This intervention is well known for its use in diminishing the fear and anxiety comprising
phobias and other fears, by systematically desensitizing a person to particular objects or situations they
fear. When treating ANV, the patient's discomfort, anxiety and nausea brought on by chemotherapy can
gradually lose their effect through systematic exposure and counter conditioning. First, a hierarchy is
created where the patient identifies which stimuli are most and least aversive. Creating an anxiety
hierarchy allows the therapist to first expose the patient to stimuli that produce the least amount of
anxiety, fear, or nausea and gradually work up to those stimuli that are most powerful. The feared
stimuli or events can be tangible (in which case the therapist would use re-exposure to the stimuli or
situation) or imagined (in which case exposure to verbal descriptions would be used). Next, the patient
is taught a relaxation technique, like progressive muscle relaxation or meditation, to be used when
therapeutic exposure to the stimuli occurs. The theory of systematic desensitization assumes that since
a state of relaxation cannot exist at the same time as a state of high anxiety, the imagined or real stimuli
that once induced anxiety or fear lose their ability to do so when repeatedly paired with relaxation.
Procedurally, once an incompatible response has been mastered (relaxation or meditation), the therapist
pairs the anxiety provoking stimulus with the meditation through counter conditioning. To do this, the
patient relaxes completely and the stimulus placed lowest on the hierarchy is presented. The client must
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reach a state of relaxation before being exposed to the next level stimuli. The patient continues to
practice the relaxation technique while systematically visualizing or being exposed to increasingly
aversive stimuli along the hierarchy. The pre-existing conditioned association will gradually diminish
the conditioned symptoms with repeated exposure. New learned associations are thought to have
arisen; those between the relaxation/meditation and the once anxiety provoking stimuli (now
neutralized).
Morrow (1986) investigated systematic desensitization in the treatment of anticipatory nausea
(AN) in cancer patients and compared the results to patients who underwent relaxation, counseling and
no treatment. Cancer patients undergoing chemotherapy and who had developed AN were assigned to
one of four conditions: systematic desensitization, relaxation only, Rogerian counseling, and a no
treatment control. Patients in the systematic desensitization group reported a significant decrease in
severity and duration of anticipatory nausea. Both systematic desensitization and relaxation were found
to help post treatment nausea relative to those who were only given counseling. Morrow’s results
supported the view that systematic desensitization is effective when it comes to the control and
reduction of anticipatory emesis developed during chemotherapy (1986). The article further supported
that both the eliciting stimulus hierarchy and counter conditioned relaxation are effective parts of
systematic desensitization treatment of AN.
Cognitive Restructuring
In cognitive restructuring, a patient is encouraged by a therapist to restructure their negative
thoughts and beliefs that contribute to the patient’s distress. Beliefs about medical treatments or
procedures can be reviewed in order to identify those that elicit fear and distress. The therapist then
guides the patient to consider other ways of viewing these stressful thoughts in order to reduce the
negative feelings and expectations. Since negative expectations can affect ANV’s development,
changing these beliefs can have a beneficial impact when treating anticipatory symptoms.
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Chen et al. (1999) was interested in reducing children’s distress during a painful medical
procedure by reframing certain aspects of the children’s memory. Children diagnosed with leukemia
had their physiological and observable distress measured before and after a painful lumbar procedure.
To reduce distress, the children were made to recall, and then more realistically appraise, their
responses to their most recent lumbar procedure. The children's confidence and beliefs regarding their
ability to cope effectively with the pain and distress was enhanced. The intervention group showed
reductions in anticipatory physiological distress and self-report ratings of anxiety compared to the
control group. "These results suggest that (a) a simple memory-based intervention is efficacious at
reducing children's distress and (b) benefits from this intervention are maintained over one week
without continued intervention" (Chen et al., 1999).
Potential Case Studies
The following potential case studies take a patient's individual characteristics, background and
risk factors into consideration and use this information to select the most viable intervention. Anxiety
plays such a large role in ANV development that many interventions include some type of technique to
reduce it. Three fictional case studies and their chosen interventions are as follows:
1) A twenty four year old female diagnosed with non-Hodgkin's lymphoma is going to undergo
her first chemotherapy infusion in the following week. She exhibits high anxiety towards treatment and
expects that the chemotherapy infusions will make her very sick. She says that in the past, she has often
suffered from car sickness and that she simply "doesn't have the stomach for this type of thing". When
measured, her trait and state anxiety were shown to be high. Being under the age of fifty and female
puts her at a higher risk for developing ANV and should be taken into account, but there are other
factors to take into consideration as well when choosing the best intervention plan. Besides her age and
gender, the patient's anxiety level and expectations put her at an even higher risk of developing
anticipatory symptoms. Knowing this, an intervention can be put together before chemotherapy starts
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to better the chances of stopping ANV from occurring or at least diminishing the effects of these
conditioned responses once treatment begins.
Relaxation training is the best intervention in this case because it will help reduce the patient's
anxiety. The patient also has a feeling that she will not be able to physically handle the chemotherapy
and the treatment is something she has little control over. When deciding between an active or passive
relaxation technique, active relaxation will be most effective because it engages the patient and creates
a sense of control over the symptoms. The therapist should coach the patient, who will learn to
gradually tense and relax her muscles and become able to control her anxiety before it reaches an
uncomfortable level. The therapist will instruct her to practice this relaxation technique at home in the
week following up to her treatment start date. She will then use her new found coping ability when she
feels stressed or anxious before her first chemotherapy session. Her active participation will help
distract her from her anxiety and give her a sense of control that can lead to a more positive outlook.
Relaxation training is commonly used because anxiety plays such a large role in ANV's occurrence and
simply reducing anxiety can lead to a better treatment experience.
To counter her negative expectations, a therapist would use cognitive restructuring that will alter
her beliefs and negative attitudes contributing to her distress. The therapist might encourage her to
examine what she imagines will happen when exposed to the anxiety-inducing stimulus (chemo) and
allow her to replace the imagined catastrophic situation with more positive outcomes and expectations.
The patient reframes the stressful life event as less threatening and, again, under her control.
2) A twelve year old boy is battling leukemia and, due to his overprotective upbringing, is
extremely anxiety sensitive. His parents have instilled that anxiety is a feeling he needs to attempt to
escape from immediately. The parents have unintentionally fostered inhibitive coping strategies and an
anxiety temperament that negatively affects whether the boy is able to avoid or cope adaptively.
Throughout the boy's young life, he watched his parents handle anxiety poorly. If he ever reported

PATIENT-BASED INTERVENTIONS IN THE TREATMENT OF ANV
feeling anxious, his parents would take him out of the situation or remove the source of the anxiety as
soon as possible. His leukemia treatment includes an extended hospital stay while he undergoes a stem
cell transplant and chemotherapy. During certain procedures like blood-draws or bone marrow biopsies,
he is hard to control and is in a state of extreme distress. While this goes on, the parents act in ways that
increase his anxiety, such as crying or acting extremely upset instead of calm and comforting. These
responses nurture his anxiety and this time there is no escape from the source. As suggested earlier, a
parent's response to anxiety can have a great impact on their child's behavior.
Parents have a significant impact on a child's behavior, whether positive or negative (Manne et
al., 1990). If a pediatric patient's parent reacts to their child's stressful medical procedures with high
levels of anxiety, it can cause great distress for the child. It's possible to teach that parent proper coping
skills to reduce anxiety but not possible or ethical to remove the parent. When the parent is taught to act
as a behavioral coach for the child, both experience less anxiety and show less distress (Manne et al.,
1990). The patient and his parents must learn to recognize, embrace, and cope with their anxiety
because high state or trait anxiety levels may contribute to the development of anticipatory symptoms.
Patients who are able to control or reduce their anxiety may therefore reduce the likelihood that they
will develop conditioned symptoms.
This intervention should aim to teach the patient how to manage his anxiety, since the source
(like chemotherapy or even the cancer itself) is out of their control. Anxiety is therefore realistically
based, and it is important to learn to accept and embrace the anxiety. Mindfulness would be the
intervention of choice in this case, but this method may be a bit too complex to explain and teach to a
child. The parents, however, would be perfect candidates. They should be trained in mindfulness
awareness and acceptance before the chemotherapy begins, and should be coach in recurring practice to
a fluent level. This would allow them to provide better support to their child and have a positive impact
on his behavior by realizing and better coping with their own distress. A popular and proven effective
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intervention for children is cognitive/attentional distraction. Video games or storytelling could be used
whenever the child is undergoing a stressful event. Combined with the parents’ efforts to reassure and
support their child, this intervention could reduce his anxiety and distress during biopsies and other
short procedures.
3) A forty year old male is undergoing chemotherapy to treat prostate cancer. After the third
chemotherapy session, he begins to feels nauseous when he sits down in the chair in which the drugs
are administered. By the sixth infusion, he begins to vomit as soon as he enters through the hospital
doors. He notices that he can no longer drink iced tea outside of the clinic because he drank it often
while undergoing chemotherapy. Even imagining the can of iced tea can elicit aversive effects for him.
The sight of the sweatshirt he usually wears to treatment makes him nauseous and uncomfortable. He
even feels sick when he meets one of the oncology nurses at a coffee shop a week after his last
infusion. Many stimuli have now come to elicit conditioned responses and it is making treatment
unbearable. He describes chemotherapy as worse than the cancer itself and he comes to dread treatment
days. His family is concerned that he might decide to stop going to treatment all together. His ANV
symptoms seem to be getting worse and are starting earlier and earlier before the treatment begins. The
oncologist prescribes him Ativan (a popular anti-anxiety drug) to take when he wakes up on treatment
days and the nurses try and administer anti-nausea medication when he arrives. However, no
pharmacological intervention seems to be helping. On top of all of this, he feels psychologically weak
because of these seemingly unjustified ANV responses.
An intervention using systematic desensitization could help lower the patient's discomfort as the
stimuli that cause these aversive symptoms can gradually lose their effect through systematic exposure.
Again, the presence of anxiety and the development of conditioned responses have a strong connection
and, in this case, treating one means treating the other. The patient, with the therapist’s help, would
create an anxiety inducing stimulus hierarchy possible starting with the can of iced tea as his least
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aversive stimulus and working up to the most aversive stimulus: sitting down in the chemotherapy
chair. The therapist would induce a relaxed state through progressive muscle relaxation or meditation,
which he learns to use when he is being exposed to the stimuli. Since a state of relaxation cannot exist
at the same time as a state of high anxiety, the patient will be able to manage the anxiety before it
reaches intolerable levels. Once an incompatible response has been mastered, the therapist connects the
stimulus to the meditation through counterconditioning. While the patient is in a relaxed state, the can
of iced tea is evoked. The patient looks at the iced tea, holds the iced tea, and may eventually drink the
iced tea. If at any time the patient feels the conditioned aversive effects, the therapist will remove the
iced tea, induce a state of relaxation once more and reattempt the exposure. Eventually, the patient will
be able to sit in the chair with the once aversive stimuli present, and achieve a relaxed state. The nurse
will gradually be able to walk over and insert the chemotherapy IV as the patient remains relaxed. The
usual negative effects of chemotherapy will not follow, and so through exposure and
counterconditioning his feelings of anticipatory nausea and vomiting will be reduced on actual
treatment days.
Discussion
Further Study
The idea that customizing these interventions lead to a more effective management of ANV
needs to be further studied. While this thesis is promising for ANV's treatment, there has been little
done to prove if the individualization of these behavioral interventions is more effective than the
current approach of using one intervention for all patients. Case studies comparing a group of patients
who undergo individualized interventions and a group that undergoes one single intervention type will
create more substantial evidence (although ultimately, well-designed randomized control trials will be
necessary).
The behavioral interventions discussed in this paper do not yet have set guidelines and much of
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the procedures’ direction and implication are left up to the therapist who implements them. More needs
to be done to find out which combinations and components of these individual procedures are most
efficient when treating conditioned symptoms. What exactly constitutes as hypnosis or meditation and
what about these interventions work needs to be established so that the most effective procedure is
used. Another promising area of study is whether combining certain interventions leads to a better
outcome in alleviating symptoms. Patients don't come in neat packages. Knowing what interventions to
combine and when to combine them may be important.
Development of Post-Traumatic Stress Disorder
A cancer diagnosis can have many negative psychological effects on a patient that can influence
their treatment as well as their lives. A study conducted by Redd (1980) showed how cancer can
negatively affect the quality of life after remission. The magnitude of this diagnosis, the patient's strong
pre-conceptions about what it means to have cancer and their aversive reactions to treatment may lead
some to develop PTSD or other related disorders. It's no secret that when left untreated cancer can be
deadly, and this realization is hard to come to terms with. More fear comes with the thought that not all
treatments end in remission, and even after remission is achieved, the fear of a recurrence can be
strong. Because of these and many other factors, some patients may need help coping with life after
remission. A sudden loss of weight or appetite can bring about the fear of recurrence, visits to a medical
facility can bring back painful memories, and thoughts about life or death can be altered in a way that
disrupts normal function. Cancer is something many patients carry with them after treatment. For
survivors, behavioral interventions can be used to reduce negative symptoms while they undergo
treatment along with symptoms that surface after remission (Smith et al., 1999). Issues like this need to
be taken into account when considering the uses of interventions like systematic desensitization and
relaxation training. During treatment, patients can be desensitized to stimuli or learn relaxation
techniques so that treatment, and life after treatment, is easier. When a patient is desensitized or learns
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these techniques, stimuli that may cause distress after remission could be better coped with. Imagined
or actual stimuli that can lead to fear, anxiety and distress can be controlled.
Conclusion
Cancer is a catastrophic diagnosis. Enduring the symptoms of ANV as well as experiencing the
stress and discomfort caused by these conditioned responses can make this diagnosis far worse. Some
come to describe the treatment worse than the cancer itself (Redd, 1988). The prevalence of ANV
makes it a worthy area of study. If it can be treated, the quality of life of cancer patients will increase,
and it will make the diagnosis that much easier to bear. Studying and applying interventions that can
make chemotherapy infusions virtually free of anticipatory side effects is a worthwhile investment.
ANV cannot be controlled by pharmacological interventions, making behavioral interventions an
important area of study (Morrow, 1996). Analyzing how ANV develops and the risk factors a patient
may have for its development can establish a better understanding of which intervention will be most
effective. Using a patient’s risk factors, coping ability, and personality traits could make it possible to
avoid the development of ANV by adequately preventing both vomiting and nausea before the first
chemotherapy (Roscoe et al., 1986). Identifying the risk factors a patient may possess before
chemotherapy begins will better the chance of this prevention. Using this type of individualized
intervention is a promising area of potential study, but has not yet been shown to be more effective than
the traditional, one-treatment-fits-all method.
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